The Chemours Company (NYSE:CC) Receives Consensus Rating of “Hold” from Analysts

Shares of The Chemours Company (NYSE:CCGet Free Report) have been assigned a consensus rating of “Hold” from the nine analysts that are presently covering the stock, Marketbeat.com reports. Five equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 1-year price target among brokers that have issued a report on the stock in the last year is $23.11.

CC has been the subject of several analyst reports. Barclays decreased their price objective on shares of Chemours from $23.00 to $19.00 and set an “equal weight” rating for the company in a research note on Monday, February 24th. BMO Capital Markets decreased their price objective on shares of Chemours from $34.00 to $27.00 and set an “outperform” rating for the company in a research note on Wednesday, February 19th. Morgan Stanley decreased their price objective on shares of Chemours from $25.00 to $22.00 and set an “equal weight” rating for the company in a research note on Monday, January 13th. Mizuho decreased their price objective on shares of Chemours from $22.00 to $21.00 and set a “neutral” rating for the company in a research note on Tuesday, January 7th. Finally, The Goldman Sachs Group decreased their price objective on shares of Chemours from $24.00 to $21.00 and set a “neutral” rating for the company in a research note on Tuesday, January 7th.

Get Our Latest Report on CC

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the business. Polar Asset Management Partners Inc. bought a new position in Chemours in the 4th quarter worth approximately $2,392,000. iSAM Funds UK Ltd bought a new position in Chemours in the 4th quarter valued at $332,000. Vision One Management Partners LP boosted its holdings in Chemours by 12.1% in the 4th quarter. Vision One Management Partners LP now owns 1,558,498 shares of the specialty chemicals company’s stock valued at $26,339,000 after purchasing an additional 168,148 shares during the period. Two Sigma Advisers LP boosted its holdings in Chemours by 31.5% in the 4th quarter. Two Sigma Advisers LP now owns 661,500 shares of the specialty chemicals company’s stock valued at $11,179,000 after purchasing an additional 158,400 shares during the period. Finally, Two Sigma Investments LP boosted its holdings in Chemours by 22.4% in the 4th quarter. Two Sigma Investments LP now owns 1,155,437 shares of the specialty chemicals company’s stock valued at $19,527,000 after purchasing an additional 211,641 shares during the period. 76.26% of the stock is owned by institutional investors.

Chemours Trading Down 0.6 %

CC opened at $14.67 on Friday. The company has a debt-to-equity ratio of 6.70, a current ratio of 1.68 and a quick ratio of 0.92. Chemours has a fifty-two week low of $13.09 and a fifty-two week high of $29.21. The firm has a market capitalization of $2.19 billion, a PE ratio of 25.73 and a beta of 2.00. The company’s 50-day moving average is $16.96 and its 200 day moving average is $18.36.

Chemours (NYSE:CCGet Free Report) last posted its earnings results on Tuesday, February 18th. The specialty chemicals company reported $0.11 earnings per share for the quarter, topping analysts’ consensus estimates of $0.10 by $0.01. Chemours had a net margin of 1.51% and a return on equity of 26.54%. The company had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.37 billion. As a group, research analysts predict that Chemours will post 2.03 earnings per share for the current fiscal year.

Chemours Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Friday, February 28th were issued a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 6.82%. The ex-dividend date was Friday, February 28th. Chemours’s dividend payout ratio (DPR) is presently 175.44%.

Chemours Company Profile

(Get Free Report

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.

Featured Stories

Analyst Recommendations for Chemours (NYSE:CC)

Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.